3Peterson RC, Doody R, Kurz A. Current concepts in mild cognitive impairment [ J ]. Arch Neurol, 2001, 58 : 1985-1992.
4Ravaglia G, Forti P, Montesi F, etal, Mild cognitive impairment epidemiology and dementia risk in an elderly Italian population [J]. J Am Geriatr Soc, 2008, 56(1) :51-58.
5Coria F, Gamezde Caso JA, M inguez L, etal, Prevalence of age- associated memory impairment and dementia in a rural community [ J]. J N eurol Neurosurg Pasychiatry, 1993, 56(9 ) :973-976.
2Panza F, Capurso C, D'Introno A, et al. Heterogeneity of mild cognitive impairment and other predementia syn- dromes in progression to dementia [J]. Neurobiol Aging, 2007,28 (10) :1631-1632.
3Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment : clinical characterization and outcome [ J ]. Arch Neurol, 1999,56 ( 3 ) : 303-308.
4Rosenberg PB, Johnston D, Lyketsos CG. A clinical ap- proach to mild cognitive impairment[ J]. Am J Psychiatry, 2006,163 ( 11 ) : 1884-1890.
5Raschetti R, Albanese E, Vanacore N, et al. Cholinesterase inhibitors in mild cognitive impairment:a systematic review of randomised trials [ J ] . PLoS Med, 2007,27,4 ( 11 ) : e338.
6Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impair- ment[ J]. N Engl J Med,2005 ,352( 23 ) :2379-2388.
